BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17347653)

  • 1. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.
    Casalino L; Bakiri L; Talotta F; Weitzman JB; Fusco A; Yaniv M; Verde P
    EMBO J; 2007 Apr; 26(7):1878-90. PubMed ID: 17347653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
    Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
    EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo.
    Battista S; de Nigris F; Fedele M; Chiappetta G; Scala S; Vallone D; Pierantoni GM; Mega T; Santoro M; Viglietto G; Verde P; Fusco A
    Oncogene; 1998 Jul; 17(3):377-85. PubMed ID: 9690519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.
    Song Y; Qian L; Song S; Chen L; Zhang Y; Yuan G; Zhang H; Xia Q; Hu M; Yu M; Shi M; Jiang Z; Guo N
    Mol Immunol; 2008 Jan; 45(1):137-43. PubMed ID: 17572495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
    Nakayama T; Hieshima K; Arao T; Jin Z; Nagakubo D; Shirakawa AK; Yamada Y; Fujii M; Oiso N; Kawada A; Nishio K; Yoshie O
    Oncogene; 2008 May; 27(23):3221-32. PubMed ID: 18071306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fos-related antigen 1 modulates malignant features of glioma cells.
    Debinski W; Gibo DM
    Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.
    Sylvester AM; Chen D; Krasinski K; Andrés V
    J Clin Invest; 1998 Mar; 101(5):940-8. PubMed ID: 9486962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.
    Maeno K; Masuda A; Yanagisawa K; Konishi H; Osada H; Saito T; Ueda R; Takahashi T
    Oncogene; 2006 Jan; 25(2):271-7. PubMed ID: 16158054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
    Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
    Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the cAMP pathway synergistically increases IL-1-induced IL-6 gene expression in FRTL-5 thyroid cells: involvement of AP-1 transcription factors.
    Szabo-Fresnais N; Blondeau JP; Pomérance M
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):28-37. PubMed ID: 18280640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity.
    Kessler R; Zacharova-Albinger A; Laursen NB; Kalousek M; Klemenz R
    Oncogene; 1999 Mar; 18(9):1733-44. PubMed ID: 10208434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.
    Talotta F; Mega T; Bossis G; Casalino L; Basbous J; Jariel-Encontre I; Piechaczyk M; Verde P
    Oncogene; 2010 Aug; 29(33):4732-40. PubMed ID: 20543861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.
    Osterloh L; von Eyss B; Schmit F; Rein L; Hübner D; Samans B; Hauser S; Gaubatz S
    EMBO J; 2007 Jan; 26(1):144-57. PubMed ID: 17159899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
    Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo.
    Adiseshaiah P; Lindner DJ; Kalvakolanu DV; Reddy SP
    Cancer Res; 2007 Jul; 67(13):6204-11. PubMed ID: 17616677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-mediated silencing of the PAR gene inhibits the growth of PC3 cells via the induction of G2/M cell cycle arrest and apoptosis.
    Xu XF; Zhang ZY; Ge JP; Cheng W; Zhou SW; Zhang X; Xu Q; Wei ZF; Gao JP
    J Gene Med; 2007 Dec; 9(12):1065-70. PubMed ID: 17902181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting c-Jun and JunB proteins as potential anticancer cell therapy.
    Gurzov EN; Bakiri L; Alfaro JM; Wagner EF; Izquierdo M
    Oncogene; 2008 Jan; 27(5):641-52. PubMed ID: 17667939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
    Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
    Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
    Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.